Additional commentary on deception in statin research.
Response to: Ferenci T. Absolute risk reduction may depend on the duration of the follow-up. Expert Rev Clin Pharmacol. 2017;10(12):1409-1410.
a Medical Research Service , Veterans Hospital , Tampa , 33612 FL , USA.|b Department of Psychology , Center for Preclinical and Clinical Research on PTSD, University of South Florida , Tampa , 33620 FL , USA.|c Department of Molecular Pharmacology and Physiology , Center for Preclinical and Clinical Research on PTSD, University of South Florida , Tampa , 33620 FL , USA.
David M
DM
Diamond
d Independent Researcher , Magle StoraKyrkogata 9 , 22350 Lund , Sweden.
Uffe
U
Ravnskov
D008192:Deception; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D061366:Numbers Needed To Treat; D012106:Research
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors